Investigators examined outcomes of robotic radiosurgery in patients with lung, visceral, and lymph node metastases from renal cell carcinoma.
The decision to discontinue was based on data from pre-planned analyses of the phase 3 PIVOT-09 study and the phase 2 PIVOT-10 study.
The risk for kidney failure requiring renal replacement therapy varies by cancer type, with multiple myeloma associated with the highest risk.
Several guidelines outline best practice for monitoring patients receiving immune checkpoint inhibitors, how to detect the early signs of these adverse events, and how to manage the events.
A minimally invasive approach does not increase risk for atypical sites of kidney cancer recurrence, a recent study suggests.